Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
about
Aspirin in the prevention and treatment of venous thromboembolismNewer strategies for the treatment of heparin-induced thrombocytopenia.Danaparoid in the prevention of thromboembolic complications.Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery.Effect of pathological heterogeneity on shear wave elasticity imaging in the staging of deep venous thrombosis.Deep vein thrombosis: a clinical review.Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery.Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review.Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications.Thromboprophylaxis in elderly patients undergoing major orthopaedic surgery.Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stabilityAntithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations.Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?Venous thromboembolic prophylaxis for hip fractures.Antiplatelet therapy in prevention of cardio- and venous thromboembolic events.The therapeutic potential of novel anticoagulants.Recent Updates of the Diagnosis and Prevention of Venous Thromboembolism in Patients with a Hip Fracture.Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study.Prophylaxis of Venous Thrombosis.
P2860
Q28199459-E5849946-CE69-459E-A35A-1C8F24E1C29FQ33327972-A77EAE35-6960-445D-B321-539D6F9CEC75Q33499807-E51C5ED3-8CCE-49BD-B941-47A9672C47DCQ33521089-0CBB2EEB-98B9-4C48-85E6-77F1E9A4841AQ33797393-A250C684-D099-4AD3-AD0B-FBBF3ED77D48Q34144439-EA274ED9-8E8B-4E7F-918C-35CC2CDDFEEDQ35160253-F217E8A8-C199-4574-A597-D21A9F6385EEQ35904940-3CAA9771-DA5E-42C2-8C19-5ABE202C2443Q35989224-121AB569-08A6-4CD6-9C33-2FF925DF2E60Q37200820-04E6D10C-4E48-45E6-BB74-2BB668BA7C2AQ37450566-345A315C-ADD5-4744-8181-9124AFAB1EBEQ37472172-8192BE83-A1FC-425F-AD11-FAF2C5D7C5B8Q37479910-9FC6B3BF-5E53-4A2E-82E2-C1D52748E0C0Q37807917-9FE9AD90-0A68-42E4-8414-0130983A267DQ38162123-C79D5266-B005-4D71-9767-E9A9455BF53EQ40409337-1533E379-35C6-4A40-9E3A-261E0D203F39Q41685198-473D2909-EBA5-499F-B492-4643DEC7A20AQ44051982-B90882CE-2872-43B3-BC3A-D8A5CE609F45Q48887406-A8A4B504-11B9-4322-BA57-F777399A6E2A
P2860
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Low-molecular-weight heparinoi ...... fter surgery for hip fracture.
@en
Low-molecular-weight heparinoi ...... fter surgery for hip fracture.
@nl
type
label
Low-molecular-weight heparinoi ...... fter surgery for hip fracture.
@en
Low-molecular-weight heparinoi ...... fter surgery for hip fracture.
@nl
prefLabel
Low-molecular-weight heparinoi ...... fter surgery for hip fracture.
@en
Low-molecular-weight heparinoi ...... fter surgery for hip fracture.
@nl
P2093
P356
P1433
P1476
Low-molecular-weight heparinoi ...... fter surgery for hip fracture.
@en
P2093
A G Turpie
J A Neemeh
J S Ginsberg
M N Levine
P J Powers
W H Geerts
P356
10.1161/01.CIR.93.1.80
P407
P577
1996-01-01T00:00:00Z